Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 PERRY GREGORY D Director Returned to the company · Stock Option (right to buy) −420 0
2023-05-31 PERRY GREGORY D Director Returned to the company · Stock Option (right to buy) −800 0
2023-05-31 Myers C. Daniel Director Grant or award +1,640 1,640
2023-05-31 Myers C. Daniel Director Returned to the company · Stock Option (right to buy) −840 0
2023-05-31 Myers C. Daniel Director Returned to the company · Stock Option (right to buy) −800 0
2023-05-31 KOVEN ANDREW I Director Grant or award +2,197 3,257
2023-05-31 KOVEN ANDREW I Director Returned to the company · Stock Option (right to buy) −518 0
2023-05-31 KOVEN ANDREW I Director Returned to the company · Stock Option (right to buy) −259 0
2023-05-31 KOVEN ANDREW I Director Returned to the company · Stock Option (right to buy) −420 0
2023-05-31 KOVEN ANDREW I Director Returned to the company · Stock Option (right to buy) −1,000 0
2023-05-31 Blumenkranz Mark S. Director Grant or award +1,640 6,807
2023-05-31 Blumenkranz Mark S. Director Returned to the company · Stock Option (right to buy) −840 0
2023-05-31 Blumenkranz Mark S. Director Returned to the company · Stock Option (right to buy) −800 0
2023-05-31 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award +2,648 25,055
2023-05-31 Kharabi Darius CHIEF BUSINESS OFFICER Returned to the company · Stock Option (right to buy) −2,000 0
2023-05-31 Kharabi Darius CHIEF BUSINESS OFFICER Returned to the company · Stock Option (right to buy) −648 0
2023-05-31 Trachtenberg Eric SEE REMARKS Grant or award +15,639 27,134
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −3,000 0
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −2,721 0
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −1,999 0

Page 8 of 12 · 236 trades